RESPIRATORY SYNCYTIAL VIRUS (RSV)
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS (RSV) explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS (RSV) trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
RSV vaccine study aims to make shots easier to store and use
⭐️ VACCINE ⭐️ CompletedThis study tested an RSV vaccine in 453 healthy women aged 18-49 to see if a multidose vial with a preservative works as well as a single-dose vial. Participants received one shot and were followed for about 6 weeks. The goal was to compare safety and immune response between the …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 05:23 UTC
-
One visit, two shots: study tests combining RSV and shingles vaccines for older adults
⭐️ VACCINE ⭐️ CompletedThis study looked at whether giving the RSV vaccine and the shingles vaccine at the same time is safe and works well in adults aged 50 and older. About 526 healthy or stable participants received either both vaccines together or one alone. Researchers measured immune responses an…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated May 19, 2026 12:00 UTC
-
RSV vaccine study: do nursing home residents get the same protection?
⭐️ VACCINE ⭐️ CompletedThis study looked at how well licensed RSV vaccines work in adults over 60 living in long-term care facilities compared to those living independently in the community. Researchers measured immune responses in 152 participants to see if the vaccines provide similar protection for …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE4 • Sponsor: University of Rochester • Aim: ⭐️ VACCINE ⭐️
Last updated May 19, 2026 11:59 UTC